Table 2. Results from the self-efficacy and attitudes questions.
| Pre | Post | p-values | |||
|---|---|---|---|---|---|
| Participants responding Strongly Disagree & Disagree/n respondents (%) | Participants responding Agree & Strongly Agree/n respondents (%) | Participants responding Strongly Disagree & Disagree/n respondents (%) | Participants responding Agree & Strongly Agree/n respondents (%) | ||
| I can recognize signs and symptoms of opioid overdose. | 5/45 (11%) | 40/45 (89%) | 0 | 46/46 (100%) | <0.001 |
| I would feel comfortable having opioid dependent patients come to my practice. | 13/45 (29%) | 32/45 (71%) | 0 | 46/46 (100%) | <0.001 |
| I would feel comfortable prescribing naloxone to a patient with opioid addiction. | 10/45 (22%) | 35/45 (78%) | 0 | 46/46 (100%) | <0.001 |
| I would feel comfortable prescribing naloxone to a family member of a patient with opioid addiction. | 12/44 (27%) | 32/44 (73%) | 1/45 (2%) | 44/45 (98%) | <0.001 |
| I am comfortable administering the intramuscular formulation of naloxone. | 20/43 (47%) | 23/43 (53%) | 4/46 (9%) | 42/46 (91%) | <0.001 |
| I am comfortable administering the intranasal formulation of naloxone. | 18/43 (42%) | 25/43 (58%) | 0 | 46/46 (100%) | <0.001 |
| I am comfortable administering the auto injector formulation of naloxone. | 23/43 (53%) | 20/43 (47%) | 0 | 46/46 (100%) | <0.001 |
| It is reasonable for a local government policy, based on available public resources, to not provide naloxone for repeat overdosers. | 29/43 (67%) | 14/43 (33%) | 33/46 (72%) | 13/46 (28%) | 0.096 |
| Increased public access to naloxone will increase risky opioid use. | 28/42 (67%) | 14/42 (33%) | 38/44 (86%) | 6/44 (14%) | 0.048 |